Showing results (141-150 of 172) with videos related to
Sort By:
Pageof 18
Science Advances|March 31, 2023
Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identityRajendran Sanalkumar, Rui Dong, Lukuo Lee, et al.Journal of Surgical Oncology|February 13, 2023
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG OncologyMark L Kayton, Aaron R Weiss, Wei Xue, et al.Journal of Hematology & Oncology|May 17, 2017
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasetsKatherine E Hill, Andrew D Kelly, Marieke L Kuijjer, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 4, 2026
Phase 1 trial of pre-operative image guided intensity modulated photon radiotherapy with simultaneously integrated boost to the high-risk margin for patients with retroperitoneal sarcomaKevin X Liu, Yen-Lin Chen, Beow Y Yeap, et al.Cancer|December 29, 2015
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaScott M Schuetze, J Kyle Wathen, David R Lucas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trialSuzanne George, Qian Wang, Michael C Heinrich, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Prognostic Significance of Percentage and Size of Dedifferentiation in Dedifferentiated ChondrosarcomaYin P Hung, Ivan Chebib, Miriam A Bredella, et al.Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.Nature Communications|August 28, 2024
EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in desmoplastic small round cell tumorsGaylor Boulay, Liliane C Broye, Rui Dong, et al.JAMA Oncology|May 1, 2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to ImatinibScott M Schuetze, Vanessa Bolejack, Dafydd G Thomas, et al.Pageof 18